Gilead ' s COVID-19 Antiviral Remdesivir Gets Conditional EU Clearance Gilead ' s COVID-19 Antiviral Remdesivir Gets Conditional EU Clearance

The European Commission said on Friday it had given conditional approval for the use of antiviral remdesivir in severe COVID-19 patients following an accelerated review process, making it the region ' s first authorized therapy to treat the virus.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news